NVO’s Ozempic Outshines LLY’s Mounjaro in Lowering Cardiovascular Risk
Novo NVO announced new real-world data from the COMPETE SWITCH Cardiovascular (CV) study comparing treatment strategies in adults…
XENE Files NDA for Epilepsy Drug, Falls on Depression Studies’ Setback
Xenon Pharmaceuticals XENE announced that it has submitted a new drug application (NDA) to the FDA for azetukalner,…
Ampco-Pittsburgh Up Nearly 217% in a Year: What’s Driving the Stock?
Ampco-Pittsburgh Corporation’s AP investors have been gaining from the stock over the past year. Shares of the Carnegie,…
Definium Reports Second Phase III Success in Anxiety Disorder Program
Definium Therapeutics DFTX reported positive late-stage data for DT120 (lysergide) orally disintegrating tablet (ODT) in generalized anxiety disorder…
IonQ Advances Quantum Computing With Superion 256: What’s Ahead?
IonQ IONQ has launched Superion 256, its sixth-generation quantum computing platform and the foundation for future compute products.…
FDA Accepts & Gives Priority Review to Intellia’s BLA for HAE Drug
Intellia Therapeutics NTLA announced that the FDA has accepted the biologics license application (BLA) seeking approval for lonvoguran ziclumeran…
Dell Reports Record Results: AI Momentum Remains Robust
Dell Technologies DELL delivered a strong report, with AI infrastructure once again reflecting the biggest highlight. Revenue climbed…
What’s Driving Quantum Computing’s Long-Term Growth Potential?
Quantum Computing Inc. QUBT or QCi completed the acquisition of NHanced Semiconductors, Inc., a U.S.-based advanced packaging foundry,…
AAOI Benefits From Strong 800G Demand: Can It Beat LITE & COHR?
Applied Optoelectronics AAOI is benefiting from accelerating demand for 800G optical transceivers, strengthening its position against Lumentum LITE…
Oracle’s Credit Risk Nears an 18-Year High: Can AI Backlog Save Stock?
Credit rating agencies have grown increasingly cautious on Oracle ORCL as the company’s aggressive artificial intelligence buildout strains…
Does EU Approval of Wegovy Pill Change NVO’s Competitive Story?
Novo Nordisk NVO received a meaningful commercial boost last week after the European Commission approved the oral version of…
Will Serve Robotics’ Healthcare Push Unlock a Bigger AI Opportunity?
Serve Robotics Inc. SERV is broadening its ambitions beyond autonomous sidewalk delivery, positioning itself as a multi-domain Physical…